share_log

Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo From January 11-12, 2023

Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo From January 11-12, 2023

MED-X 將於 2023 年 1 月 11 日至 12 日在目標特色產品國家會議和博覽會上展示自然產品組合
Accesswire ·  2023/01/09 21:37

Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo from January 11-12, 2023

MED-X 將於 2023 年 1 月 11 日至 12 日在目標特色產品國家會議和博覽會上展示自然產品組合

LOS ANGELES, CA / ACCESSWIRE / January 9, 2023 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that the Company will attend the 2023 Target Specialty Products National Meeting and Expo ("TSP Expo") from January 11-12, 2023 in Phoenix, Arizona.

加利福尼亞州洛杉磯交通線/2023 年 1 月 9 日/ MED-X, 公司 作為針對害蟲控制、健康和保健市場的全天然綠色場景解決方案的領先創新者,今天宣布,該公司將參加 2023 年 目標特色產品 全國會議和博覽會 (「TSP 博覽會」) 從 1 月 11-12, 2023 在鳳凰城, 亞利桑那.

The TSP Expo is a national meeting that brings together the top industry suppliers and TSP sales representatives as well as their respective management teams to understand the needs and wants of national pest control operators serviced by Target Specialty Products, a leading value-added service provider to the pest control industry, which allows them to speak to suppliers to evaluate solutions for their respective pest control business customers. The TSP Expo presents a significant sales opportunity to continue converting and adding pest control businesses to the use of Nature-Cide products for the 2023 fiscal year and beyond.

TSP Expo 是一個全國性的會議,匯集了頂級行業供應商和 TSP 銷售代表以及各自的管理團隊,以了解由 Target Specipecitions 提供服務的全國害蟲控制運營商的需求和需求,這使他們能夠與供應商交談,以評估其各自害蟲控制業務客戶的解決方案。TSP 展覽會提供了一個重要的銷售機會,可以在 2023 會計年度及以後繼續將害蟲控制業務轉化並將其添加到 Nature-Cide 產品的使用中。

2023 TSP National Meeting + Expo
Date: January 11-12, 2023
Location: Hilton Phoenix Resort at the Peak | Phoenix, AZ
Booth: Number 35

2023 茶匙全國會議 + 博覽會
日期:二零二三年一月十一日至十二日
地點:希爾頓鳳凰山頂度假村 | 亞利桑那州鳳凰城
攤位:35 號

"I am thrilled to attend this incredibly prominent industry event alongside leading national companies such as BASF, FMC and Syngenta - offering ground breaking all-natural solutions to pest control operators, giving them a tool of less environmental impact and exposure to choose from," said Matthew Mills, Chief Executive Officer of Med-X. "The TSP Expo offers an exciting opportunity to continue to place our products in front of potentially thousands of pest control operators continent-wide, providing the chance to become the de-facto standard product line for operators in 2023 and beyond. I look forward to sharing our capabilities at the TSP Expo later this week as we strive to create sustainable, long-term value for our shareholders."

MED-X 首席執行官 Matthew Mills 表示:「我很高興能與巴斯夫、FMC 和 Syngenta 等領先的國家公司一起參加這一令人難以置信的重要行業活動,為害蟲控制運營商提供突破性的全天然解決方案,為他們提供了較少的環境影響和曝光度的工具。TSP Expo 提供了一個令人興奮的機會,繼續將我們的產品放在全洲數千名害蟲控制操作員的面前,從而為 2023 年及以後的運營商提供了成為實際標準產品線的機會。我期待在本週晚些時候在 TSP 博覽會上分享我們的能力,同時我們努力為股東創造可持續的長期價值。」

About Med-X, Inc.

關於 MED-X 公司

Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .

醫生-X 公司 是全天然綠色場景解決方案的領先創新者,致力於解決國際 害蟲控制, 健康健康 市場。MED-X 利用其多元化的內部品牌系列,為使用全天然成分的傳統化學和製藥產品提供安全替代品,全面的進入市場策略包括整合式電子商務、實體和砂漿經銷商,以及主要國家市場的現場服務。欲了解更多信息,請訪問 。

Disclaimer and Forward-Looking Statements

免責聲明及前瞻性聲明

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.

本新聞稿並不構成出售要約或徵求購買任何證券的要約。任何要約,招攬或要約購買,或任何出售證券將根據經修訂的 1933 年證券法的註冊要求進行(「證券法」)。本公告按照《證券法》第 135 條發布。本新聞稿可能包含有關預期業務績效、營運業績、財務狀況和公司其他方面的前瞻性陳述,並以「預期」、「預期」和「預測」等語言表示。請注意,這些陳述僅為估計值,並不保證前瞻性陳述所述或暗示的結果實際上是由公司實現的。前瞻性陳述可能基於證明是錯誤的管理假設。本公司及其業務須承受超出其控制範圍的重大風險和潛在事件,這些事件將導致預測結果與實際業績之間的重大差異,包括本公司造成營運損失,以及發生意外的重大不良事件。

Investor Relations Contact

投資者關係聯絡

Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us

卢卡斯·齐默尔曼
導向器
MZ 集團-MZ 北美
262-357-2918
MXRX@mzgroup.us

SOURCE: Med-X, Inc.

來源: 醫生-X 公司


View source version on accesswire.com:
檢視網站上的原始碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論